Pulmonx (STU:4NI) Stock Based Compensation : €21.38 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Pulmonx Stock Based Compensation?

Pulmonx's Stock Based Compensation for the three months ended in Mar. 2024 was €5.22 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 was €21.38 Mil.

Pulmonx Stock Based Compensation Historical Data

The historical data trend for Pulmonx's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulmonx Stock Based Compensation Chart

Pulmonx Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Stock Based Compensation

Get a 7-Day Free Trial

0.32

2.63

9.32

15.53

20.27

Pulmonx Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Stock Based Compensation	Get a 7-Day Free Trial															4.33	5.41	5.62	5.14	5.22

Pulmonx Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €21.38 Mil.

Pulmonx Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Pulmonx's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Pulmonx (STU:4NI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulmonx Corp (STU:4NI) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

LUNG:USA

Address

700 Chesapeake Drive, Redwood, CA, USA, 94063

Website

https://www.pulmonx.com

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the U.S. and international markets.

Pulmonx (STU:4NI) Headlines

No Headlines